curesickle.org valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# # robots.txt # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html # # For syntax checking, see: # http://www.frobee.com/robots-txt-check User-agent: * Crawl-delay: 10 # Directories Disallow: /includes/ Disallow: /misc/ Disallow: /modules/ Disallow: /profiles/ Disallow: /scripts/ Disallow: /themes/ # Files Disallow: /CHANGELOG.txt Disallow: /cron.php Disallow: /INSTALL.mysql.txt Disallow: /INSTALL.pgsql.txt Disallow: /INSTALL.sqlite.txt Disallow: /install.php Disallow: /INSTALL.txt Disallow: /LICENSE.txt Disallow: /MAINTAINERS.txt | ||
Meta Tags
| Title | Cure Sickle Cell Initiative | Advancing research in sickle cell disease | Cure Sickle |
| Description | SOURCE: THE NATIONAL INSTITUTES OF Following a long tradition of advancing research in sickle cell disease, the National Heart, Lung, and Blood Institute (NHLBI) launched the Cure Sickle Cell Initiative in September |
| Keywords | Cure Sickle Cell Initiative, NHLBI, NIH, Cure Sickle Cell, Sickle Cell Disease, Curing Sickle Cell, Genetic Therapies, Genetic Cure, Genetic Based Cures, Genetic, Cure, Cures, Therapy, Therapies |
Server Information
| WebSite | |
| Host IP | 65.123.194.180 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
curesickle.org Valuation
|
US$6,714,876
Last updated: 2023-05-07 01:24:30
curesickle.org has Semrush global rank of 1,576,247. curesickle.org has an estimated worth of US$ 6,714,876, based on its estimated Ads revenue. curesickle.org receives approximately 774,794 unique visitors each day. Its web server is located in United States, with IP address 65.123.194.180. According to SiteAdvisor, curesickle.org is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,714,876 |
| Daily Ads Revenue | US$6,199 |
| Monthly Ads Revenue | US$185,951 |
| Yearly Ads Revenue | US$2,231,405 |
| Daily Unique Visitors | 51,653 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| curesickle.org. | A | 590 | IP: 65.123.194.180 |
| curesickle.org. | NS | 3600 | NS Record: ns16.domaincontrol.com. |
| curesickle.org. | NS | 3600 | NS Record: ns15.domaincontrol.com. |
HtmlToTextCheckTime:2023-05-07 01:24:30
| × Log in --> About Overview The Initiative Leadership Community Input Panel FAQs Patient & Advocacy Community Overview & Stories Genetic Therapies Clinical Trials Resource Library Scientific Community Overview Scientific Activities & Updates Funding & Research Opportunities Research Resources Data Standards & Tools Overview Data Standards CRF Library CDE Catalog News & Updates Contact General Researcher Member Login × Launch of the Phase 2 Gene Therapy to Reduce All Sickle Pain (GRASP) Clinical Trial Announced. Read more . × The Cure Sickle Cell Initiative (CureSCi) is pleased to announce the launch of the Gene Therapy to Reduce All Sickle Pain (GRASP) Trial, part of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). This Phase 2, multi-center trial is designed to test whether the gene therapy approach (lentiviral vector shmiR), which decreases expression of the BCL11A gene, can improve or eliminate sickle cell pain episodes. Trial participants will include people |
curesickle.org Whois Information
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS |